Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Matthew Cooper's photo - Co-Founder & CEO of Inflazome

Co-Founder & CEO

Matthew Cooper

CEO Approval Rating

89/100

Inflazome is a biotech company that develops and commercializes molecular-targeted drug therapies for the treatment of inflammatory diseases. Read more